Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, August 11, 2020
[ Tue, Aug 11th 2020
] - WOPRAI
[ Tue, Aug 11th 2020
] - WOPRAI
[ Tue, Aug 11th 2020
] - WOPRAI
[ Tue, Aug 11th 2020
] - WOPRAI
[ Tue, Aug 11th 2020
] - WOPRAI
[ Tue, Aug 11th 2020
] - WOPRAI
[ Tue, Aug 11th 2020
] - WOPRAI
[ Tue, Aug 11th 2020
] - WOPRAI
[ Tue, Aug 11th 2020
] - WOPRAI
[ Tue, Aug 11th 2020
] - WOPRAI
[ Tue, Aug 11th 2020
] - WOPRAI
[ Tue, Aug 11th 2020
] - WOPRAI
[ Tue, Aug 11th 2020
] - WOPRAI
[ Tue, Aug 11th 2020
] - WOPRAI
[ Tue, Aug 11th 2020
] - WOPRAI
[ Tue, Aug 11th 2020
] - WOPRAI
[ Tue, Aug 11th 2020
] - WOPRAI
[ Tue, Aug 11th 2020
] - WOPRAI
[ Tue, Aug 11th 2020
] - WOPRAI
[ Tue, Aug 11th 2020
] - WOPRAI
[ Tue, Aug 11th 2020
] - WOPRAI
[ Tue, Aug 11th 2020
] - WOPRAI
[ Tue, Aug 11th 2020
] - WOPRAI
[ Tue, Aug 11th 2020
] - WOPRAI
[ Tue, Aug 11th 2020
] - WOPRAI
[ Tue, Aug 11th 2020
] - WOPRAI
Mon, August 10, 2020
[ Mon, Aug 10th 2020
] - WOPRAI
Matthew Harrison Maintained (SRPT) at Buy with Increased Target to $182 on, Aug 10th, 2020
Matthew Harrison of Morgan Stanley, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Buy with Increased Target from $172 to $182 on, Aug 10th, 2020.
Matthew has made no other calls on SRPT in the last 4 months.
There is 1 other peer that has a rating on SRPT. Out of the 1 peers that are also analyzing SRPT, 0 agree with Matthew's Rating of Hold.
This is the rating of the analyst that currently disagrees with Matthew
- Tazeen Ahmad of "B of A Securities" Maintained at Strong Buy and Held Target at $180 on, Wednesday, June 10th, 2020
Similar Stocks and Investing Articles
[ Wed, Jun 10th 2020
] - WOPRAI
[ Wed, Apr 15th 2020
] - WOPRAI
[ Tue, Mar 31st 2020
] - WOPRAI
[ Fri, Mar 27th 2020
] - WOPRAI
[ Wed, Aug 22nd 2018
] - WOPRAI
[ Wed, Aug 22nd 2018
] - WOPRAI
[ Thu, Jul 27th 2017
] - WOPRAI
[ Thu, Jul 20th 2017
] - WOPRAI
[ Mon, Jul 17th 2017
] - WOPRAI
[ Mon, Mar 19th 2012
] - WOPRAI